COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,432 Articles (22,835 medRxiv, 8,597 bioRxiv)

Most recent first Previous |  Page 11: Articles 101-110  | Next

Identification of MED13 and DDX60 as critical host factors for SARS-CoV-2 infections
Kwon, H., Wai, S. T., Michlits, G., Dyczynski, M., Markovic, A., Rocha Berger, A. S. B., JOHN, L., Horn, M., Weber, F., Penninger, J. M., Monteil, V., Mirazimi, A.
10.64898/2026.02.25.707691 — Posted: 2026-02-25
Bayesian generative modeling for heterogeneous wastewater data applied to COVID-19 forecasting
Johnson, K. E., Vega Yon, G., Brand, S. P. C., Bernal Zelaya, C., Bayer, D., Volkov, I., Susswein, Z., Magee, A., Gostic, K. M., English, K. M., Ghinai, I., Hamlet, A., Olesen, S. W., Pulliam, J., Abbott, S., Morris, D. H.
10.64898/2026.02.23.26346887 — Posted: 2026-02-24
Alcov2: a National Questionnaire Survey for Understanding the Transmission of SARS-CoV-2 in French Households during First Lockdown
Lambert, A., Bonnet, A., Clavier, P., Biousse, P., Clavieres, L., Brouillet, S., Chachay, S., Jauffret-Roustide, M., Lewycka, S., Chesneau, N., Nuel, G.
10.64898/2026.02.23.26344954 — Posted: 2026-02-24
Automated Model Discovery Based on COVID-19 Epidemiologic Data
Babazadeh Shareh, M., Kleiner, F., Böhme, M., Hägele, C., Dickmann, P., Heintzmann, R.
10.64898/2026.02.22.26346850 — Posted: 2026-02-24
AVE0991, a Mas receptor agonist, increases influenza and COVID-19 severity in vivo.
Wu, M., Sng, J. D. J., Noye, E. C., McCallum, G., Bielefeldt-Ohmann, H., Foo, C. X., Ronacher, K., Chew, K. Y., Short, K. R.
10.64898/2026.02.23.707600 — Posted: 2026-02-24
Genetic Evidence Indicates the Evolutionary Importance of the SARS-CoV-2 ORF9b protein
Hisner, R., Martin, D. P.
10.64898/2026.02.23.707522 — Posted: 2026-02-24
Reclaiming health: a qualitative, explorative study of long covid recovery journeys involving mind-body approaches.
Deurman, C., Brinkman, V., Slagboom, M., Bussemaker, J., Vos, H. M. M.
10.64898/2026.02.21.26345052 — Posted: 2026-02-23
Genomic Evolution of SARS-CoV-2 Delta Variants Pre- and Post-Omicron Emergence using Alignment-free Machine Learning models
Sankar, S., Anandharaman, K., Selvam, P., Jayaraman, A., Jayakumar, D., Sivadoss, R., Esaki Muthu, S., Velu, V., Larsson, M., Balakrishnan, P.
10.64898/2026.02.20.706927 — Posted: 2026-02-23
PFOA induced metabolic and immune perturbations in a SARS-2 infection model
Lanier, D. N., Rowe Haas, D., Uchimiya, M., Jones, C., Johnson, S., Sakamoto, K., Chappel, J. R., Fry, A. N., Leach, F. E., DeWitt, J., Woodlief, T., Gaul, D. A., Baker, E. S., Fernandez, F. M., Tompkins, S. M., Edison, A. S.
10.64898/2026.02.21.707085 — Posted: 2026-02-23
Randomized incentives to increase participation in COVID testing in rural Kenya
Chieng, B., Crider, Y., Aitken, C., Araka, S. B., Kihoro, R. W., Kanyi, H., Powers, J. E., Tan, B., Paulos, A. P., Gomes, A. S., Nekesa, C., Nekesa, C., Bwire, B., Allela, D. O., Kiiru, J. N., Kremer, M., Njenga, S., Pickering, A.
10.64898/2026.02.15.26346122 — Posted: 2026-02-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).